Catalyst Wire Dossier Catalyst Wire Dossier

TOUR006

· Tourmaline Bio, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TOUR006, covering 2026-02-24 to 2026-08-11. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP [Phase 2]

See pricing